
News|Articles|August 19, 2011
FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults
FDA has approved emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Complera, Gilead Sciences), a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.
Advertisement
FDA approves single-tablet regimen for HIV-1 infection in treatment-naïve adults
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Capital Rx is now Judi Rx in a company rebrand
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Biomarker-guided PARP inhibition shows durable benefit in hormone-sensitive prostate cancer
4
Most patients with acute pain use opioids sparingly, study finds
5



























